Uterine fibroids are the most common benign tumour of the female genital tract. However,
their true prevalence is probably under-estimated, as the incidence at histology is more than …

BACKGROUND Abnormal uterine bleeding (AUB) has a significant socioeconomic impact
since it considerably impacts quality of life. Therapeutic options are frequently based on trial …

There is general inconsistency in the nomenclature used to describe abnormal uterine
bleeding (AUB), in addition to a plethora of potential causes—several of which may coexist …

At this juncture, clinical management, education for medical providers, and the design and
interpretation of clinical trials have been hampered by the absence of a consensus system …

In November 2010, the International Federation of Gynecology and Obstetrics formally
accepted a new classification system for causes of abnormal uterine bleeding in the …

Abstract Tranexamic acid (Transamin®, Cyklokapron®, Exacyl®, Cyklo-f®) is a synthetic
lysine derivative that exerts its antifibrinolytic effect by reversibly blocking lysine binding sites …

The gynaecological and obstetric management of women with inherited coagulation
disorders requires close collaboration between obstetrician/gynaecologists and …

Antifibrinolytics for heavy menstrual bleeding - Bryant‐Smith, AC - 2018 | Cochrane Library Skip
to Content Cookies Our site uses cookies to improve your experience. You can find out more …

Endometriosis, defined as the presence of endometrial tissue outside the uterus, is an
estrogen-dependent disease which causes pelvic pain and subfertility in women of …

abstract Context: Uterine leiomyomas occur in 30–70% of reproductive-age women.
Leiomyoma reduce implantation, increase miscarriage risk, and increase menstrual …